Glaukos Corporation (GKOS)

95.13 -1.76 (-1.82%) At close: 04:00PM EDT

Glaukos Corporation

One Glaukos Way
Aliso Viejo, CA 92656
United States
949 367 9600
https://www.glaukos.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 907

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Thomas William Burns	Chairman & CEO	1.5M	N/A	1961
Mr. Joseph E. Gilliam	President & COO	974.59k	N/A	1976
Mr. Alex R. Thurman	Senior VP & CFO	373.4k	N/A	1970
Mr. Chris M. Calcaterra	Executive Vice President of Global Commercial Operations	198.66k	N/A	1960
Dr. Tomas Navratil Ph.D.	Chief Development Officer	721.51k	N/A	1977
Dr. Mory Gharib Ph.D.	Co-Founder	N/A	N/A	N/A
Mr. Christopher William Lewis	Vice President of Investor Relations & Corporate Affairs	N/A	N/A	N/A
Ms. Diana A. Scherer	VP of Compliance & Deputy General Counsel	N/A	N/A	N/A
Ms. Michele M. Allegretto	Senior Vice President of Human Resources	N/A	N/A	N/A
Ms. Jane E. Rady	Senior Vice President of Corporate Strategy & Business Development	N/A	N/A	1948

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Corporate governance

Glaukos Corporation’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.